MIM
BHVN icon

Monashee Investment Management’s Biohaven BHVN Stock Holding History

Monashee Investment Management’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-90,000
Closed -$2.34M – 52
2023
Q3 		$2.34M Buy
90,000
+40,000
+80% +$831K 0.98% 38
2023
Q2 		$1.2M Sell
50,000
-200,000
-80% -$3.44M 0.29% 53
2023
Q1 		$3.42M Buy
250,000
+50,000
+25% +$796K 0.94% 23
2022
Q4 		$2.78M Sell
200,000
-209,200
-51% -$2.95M 1.19% 26
2022
Q3 		$2.52M Buy
+409,200
New +$2.97M 0.93% 17

Other funds holding BHVN

Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RM
RP Management New York $139M AUM 37.98% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Monashee Investment Management's BHVN Position: Q4 2023 in Review

Monashee Investment Management sold out of Biohaven (BHVN) in Q4 2023, closing a stake of 90,000 shares — an estimated $2.34M sold.

Monashee Investment Management first reported a position in BHVN in Q3 2022 and held it in 5 quarters. The position peaked at $3.42M in Q1 2023. 218 funds tracked by Wall St. Rank hold BHVN as of Q4 2023.

  • Monashee Investment Management reported no remaining Biohaven position as of Q4 2023 after selling out during the quarter.
  • Monashee Investment Management sold 90,000 Biohaven shares in Q4 2023, an estimated $2.34M.
  • Monashee Investment Management first reported a position in Biohaven in Q3 2022 and held it in 5 quarters.
  • Monashee Investment Management's Biohaven position peaked at $3.42M in Q1 2023.
  • 218 funds tracked by Wall St. Rank held Biohaven as of Q4 2023.

Based on Monashee Investment Management's 13F filing for Q4 2023, filed 12 Feb 2024.